Pharmaceuticals 2010, 3(8), 2733-2750; doi:10.3390/ph3082733
Review

Dendritic Cell Regulation by Cannabinoid-Based Drugs

Received: 2 July 2010; in revised form: 11 August 2010 / Accepted: 20 August 2010 / Published: 23 August 2010
(This article belongs to the Special Issue Cannabinoids)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Cannabinoid pharmacology has made important advances in recent years after the cannabinoid system was discovered. Studies in experimental models and in humans have produced promising results using cannabinoid-based drugs for the treatment of obesity and cancer, as well as neuroinflammatory and chronic inflammatory diseases. Moreover, as we discuss here, additional studies also indicates that these drugs have immunosuppressive and anti-inflammatory properties including modulation of immune cell function. Thus, manipulation of the endocannabinoid system in vivo may provide novel therapeutic strategies against inflammatory disorders. At least two types of cannabinoid receptors, cannabinoid 1 and cannabinoid 2 receptors are expressed on immune cells such as dendritic cells (DC). Dendritic cells are recognized for their critical role in initiating and maintaining immune responses. Therefore, DC are potential targets for cannabinoid-mediated modulation. Here, we review the effects of cannabinoids on DC and provide some perspective concerning the therapeutic potential of cannabinoids for the treatment of human diseases involving aberrant inflammatory processes.
Keywords: Cannabinoids; dendritic cells; inflammation; immunomodulation; KV-channels
PDF Full-text Download PDF Full-Text [318 KB, uploaded 23 August 2010 15:35 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Svensson, M.; Chen, P.; Hammarfjord, O. Dendritic Cell Regulation by Cannabinoid-Based Drugs. Pharmaceuticals 2010, 3, 2733-2750.

AMA Style

Svensson M, Chen P, Hammarfjord O. Dendritic Cell Regulation by Cannabinoid-Based Drugs. Pharmaceuticals. 2010; 3(8):2733-2750.

Chicago/Turabian Style

Svensson, Mattias; Chen, Puran; Hammarfjord, Oscar. 2010. "Dendritic Cell Regulation by Cannabinoid-Based Drugs." Pharmaceuticals 3, no. 8: 2733-2750.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert